Blood Advances | 2019
Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
Solomon SR, St. Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang M-J, Eapen M
PubMed
PMID: 31582392
Abstract
Related Articles
CIBMTR Study #: GS17-02